Comments
Aurobindo Pharma Ltd has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Valsartan Tablets.
The product is ready for launch, the Hyderabad based company said in release on Tuesday.
Valsartan tablets are the generic equivalent to the reference listed drug product (RLD) Diovan of Novartis Pharmaceuticals Corporation (Novartis) and indicated for the treatment of hypertension, to lower blood pressure.
The product falls under the therapeutic category of CVS (Cardio Vascular) has a market size of approximately US$ 2 billion for the twelve months ending October 2014 according to IMS, according to a release.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.